Skip to content
Home/Companies/Healthcare/Precision BioLogic

Precision BioLogic

Healthcare·Canada·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Precision BioLogic?

Precision BioLogic is currently owned by Procuritas Capital Investors through PCI VII (2022 vintage), since 2024.

Hand-verified · updated 2026-08-17

Procuritas Capital Investors
Investor
Procuritas Capital Investors
PCI VII · 2022 · Small-Mid Buyout

Key facts

HQCanada
SectorHealthcare
StatusActive

More from PCI VII

Other portfolio companies in the same fund.

Parkman
Active
Business ServicesSweden· 2025
Energima
Active
Business ServicesNorway· 2024
PropTech
Active
Real EstateSweden· 2023
Nordic Biomarker
Active
HealthcareSweden· 2022
Werksta
Active
Business ServicesSweden· 2022
weselect
Active
HR TechSweden· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Precision BioLogic

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Precision BioLogic?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Precision BioLogic.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue